Clinical Trials Browser

Phase 2 × INDUSTRY × Mastocytosis, Cutaneous × Clear all

NCT00457288 2007-11-12

Efficacy and Safety of TF002 in Cutaneous Mastocytosis

Phase 2 Completed

DermatologicMyeloid

Mastocytosis, Cutaneous